BI 1323495 clinical trials
Also written BI 1323495.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses BI 1323495 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- BI 1323495
- 6
Studies by the year they started
7 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses BI 1323495 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of InflammationTerminatedPhase 1Boehringer IngelheimNCT04656275Written as BI 1323495
- A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the BloodCompletedPhase 1Boehringer IngelheimNCT04619251Written as BI 1323495
- A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the BloodCompletedPhase 1Boehringer IngelheimNCT04257032Written as Rosuvastatin + BI 1323495
- A Study to Test How Food Influences the Amount of BI 1323495 in the Blood of Healthy MenCompletedPhase 1Boehringer IngelheimNCT03802331Written as BI 1323495,
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1323495 in the BloodCompletedPhase 1Boehringer IngelheimNCT04011241Written as BI 1323495
- This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated.CompletedPhase 1Boehringer IngelheimNCT03588390Written as BI 1323495
- A Study in Healthy Men and Women to Test How Well Different Doses of BI 1323495 Are ToleratedCompletedPhase 1Boehringer IngelheimNCT04107805Written as BI 1323495